Page results
-
When the Lighthouse opened in 2018, it was the first establishment of its kind in the UK, offering a safe place for children and young people who have experienced sexual abuse.
-
What happens after seeing the doctor? Your doctor will decide whether you need any follow up, by telephone or face to face, or whether your results can be communicated to you in a…
-
Who we are - a community, not just a charity The Friends of UCLH have been supporting UCLH for many years, before that supporting the individual hospitals that came together to form UCLH.…
-
A programme of wellbeing classes, workshops and courses. It includes activities which give advice and/or support to help people to manage the physical and emotional impact of cancer or a blood condition.
-
Support groups for anyone affected by cancer or a blood condition, including family, friends and carers.
-
Acupuncture is the insertion of solid needles into the body to improve health. The needles are very fine, much thinner than needles used to give injections or take blood samples. We use sterile needles. They are disposable and never reused.
-
A directory of resources giving advice and support to help people to manage the impact of cancer and blood conditions.
-
Publications
-
We are a specialist Children and Young People's (CYP) Endocrinology Service. We also have access to the specialist adolescent psychology service, play specialists, and safeguarding team and are supported by a team of admin staff.
File results
-
FOI/2023/0356 - Current wait time for referral to treatment with a consultant for osteoporosis
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy